UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

Diabetic medicine, 2007-01, Vol.24 (1), p.1-6

Targher, G.

2007

Link zum Volltext

Verfügbarkeit prüfen

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

Diabetologia, 2008-11, Vol.51 (11), p.1947-1953

2008

Link zum Volltext

Verfügbarkeit prüfen

Global epidemiology of nonalcoholic fatty liver disease: Meta‐analytic assessment of prevalence, incidence, and outcomes

Hepatology (Baltimore, Md.), 2016-10, Vol.64 (4), p.1388-1389

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Diabetes & metabolism, 2020-11, Vol.46 (6), p.427-441

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies

Journal of endocrinological investigation, 2022-07, Vol.45 (7), p.1277-1288

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

Diabetologia, 2008-03, Vol.51 (3), p.444-450

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?

Diabetes & metabolism, 2016-06, Vol.42 (3), p.142-156

2016

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Journal of endocrinological investigation, 2015-08, Vol.38 (8), p.817-825

2015

Link zum Volltext

Verfügbarkeit prüfen

Mortality from infectious diseases in diabetes

Nutrition, metabolism, and cardiovascular diseases, 2018-05, Vol.28 (5), p.444-450

2018

Link zum Volltext

Verfügbarkeit prüfen

Patients with diabetes are at higher risk for severe illness from COVID-19

Diabetes & metabolism, 2020-09, Vol.46 (4), p.335-337

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis

Diabetes & metabolism, 2019-12, Vol.45 (6), p.536-544

2019

Link zum Volltext

Verfügbarkeit prüfen

Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes

Diabetes & metabolism, 2020-09, Vol.46 (4), p.296-303

2020

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

Diabetic medicine, 2005-10, Vol.22 (10), p.1354-1358

2005

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

Diabetologia, 2010-07, Vol.53 (7), p.1341-1348

2010

Link zum Volltext

Verfügbarkeit prüfen

Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes

Diabetes & metabolism, 2020-09, Vol.46 (4), p.326-330

2020

Link zum Volltext

Verfügbarkeit prüfen

Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography

Diabetes & metabolism, 2020-04, Vol.46 (2), p.150-157

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease

Diabetes & metabolism, 2019-10, Vol.45 (5), p.480-487

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease

Diabetes & metabolism, 2021-02, Vol.47 (1), p.101152-101152, Article 101152

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

Diabetic medicine, 2012-02, Vol.29 (2), p.220-226

2012

Link zum Volltext

Verfügbarkeit prüfen

Psychological distress, self-efficacy and glycemic control in type 2 diabetes

Nutrition, metabolism, and cardiovascular diseases, 2017-04, Vol.27 (4), p.300-306

2017

Link zum Volltext

Verfügbarkeit prüfen

Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study

Diabetes research and clinical practice, 2021-07, Vol.177, p.108884-108884, Article 108884

2021

Link zum Volltext

Verfügbarkeit prüfen

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

Diabetes & metabolism, 2020-11, Vol.46 (6), p.505-507

2020

Link zum Volltext

Verfügbarkeit prüfen

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006

Nutrition, metabolism, and cardiovascular diseases, 2010-10, Vol.20 (8), p.583-590

2010

Link zum Volltext

Verfügbarkeit prüfen

Association between increased carotid intima–media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes

Diabetes & metabolism, 2020-10, Vol.46 (5), p.409-411

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides

Journal of endocrinological investigation, 2021-03, Vol.44 (3), p.547-555

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(163)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(130)
Humans
(114)
Male
(90)
Endocrinology & Metabolism
(89)
Female
(76)
Adult
(62)
Middle Aged
(57)
Biological And Medical Sciences
(55)
Medical Sciences
(52)
Risk Factors
(44)
Aged
(39)
Endocrinopathies
(33)
Diabetes. Impaired Glucose Tolerance
(30)
Endocrine Pancreas. Apud Cells
(30)
Diabetes
(27)
Body Mass Index
(26)
Type 2 Diabetes
(26)
Cardiovascular System & Cardiology
(24)
Metabolic Diseases
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

Global epidemiology of nonalcoholic fatty liver disease: Meta‐analytic assessment of prevalence, incidence, and outcomes

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?

Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Mortality from infectious diseases in diabetes

Patients with diabetes are at higher risk for severe illness from COVID-19

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis

Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes

Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease

Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

Psychological distress, self-efficacy and glycemic control in type 2 diabetes

Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006

Association between increased carotid intima–media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes

Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides

Suchergebnisse filtern